March 24, 2025

High Treatment-Resistant Depression Rates in Real-World Depression Cohort

Researchers found that nearly half of patients with major depressive disorder met criteria for treatment-resistant depression.

Conexiant

March 24, 2025

Influencing Geriatric Oncology Practice Worldwide: 2024 International Society of Geriatric Oncology Conference

The Annual Meeting of the International Society of Geriatric Oncology (SIOG) was held from October 17–19, 2024, in Montreal. The conference theme was “Promoting Equity and Enhancing Optimal Care Deliv...

The ASCO Post

March 24, 2025

HS Guidelines for Special Populations

"These guidelines address the unique needs of diverse groups typically underrepresented in clinical trials, and highlight the importance of a multidisciplinary approach."

Conexiant

March 24, 2025

Tildrakizumab Shows Lasting Efficacy in Scalp Psoriasis

Tildrakizumab may provide durable response for scalp psoriasis, a phase 3b study found, confirming sustained efficacy and safety through 52 weeks.

Conexiant

March 24, 2025

Cannabis Use: Multicenter Study Links to Increased MI, Stroke Risks

Cannabis use associated with over sixfold higher risk of myocardial infarction in otherwise healthy adults, according to new multicenter study.

Conexiant

March 24, 2025

inMIND Trial: Tafasitamab Plus Lenalidomide and Rituximab in Relapsed or Refractory Follicular Lymphoma

The addition of tafasitamab, a CD19 monoclonal antibody, to the commonly used lenalidomide and rituximab backbone significantly improved progression-free survival in patients with relapsed or refracto...

The ASCO Post

March 24, 2025

Sex Differences in Asthma and COPD Hospital Admission Outcomes: Study

Females with asthma had 'higher odds of readmission within 30 and 90 days' compared with males, according to a new study on sex differences in asthma and COPD outcomes.

Conexiant

March 24, 2025

Ageism and Its Role in the Treatment of Cancer

Learn about the increasing prevalence of ageism and its impact on healthcare access, quality of life, and workforce preparedness in geriatric care.

The ASCO Post

March 24, 2025

Benefit Suggested for Early Treatment of Advanced-Stage, Very Low–Tumor Burden Follicular Lymphoma

In the phase III JCOG1411/FLORA trial of patients with untreated advanced-stage, very low–tumor burden follicular lymphoma, rituximab induction delayed disease progression to high–tumor burden follicu...

The ASCO Post